Works by Jeschke, Udo


Results: 257
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 8719, doi. 10.1007/s00432-023-04708-z
    By:
    • Reichenbach, Juliane;
    • Fraungruber, Patricia;
    • Mayr, Doris;
    • Buschmann, Christina;
    • Kraus, Fabian B. T.;
    • Topalov, Nicole Elisabeth;
    • Chelariu-Raicu, Anca;
    • Kolben, Thomas;
    • Burges, Alexander;
    • Mahner, Sven;
    • Kessler, Mirjana;
    • Jeschke, Udo;
    • Czogalla, Bastian;
    • Trillsch, Fabian
    Publication type:
    Article
    17
    18

    MTA1 as negative prognostic marker in vulvar carcinoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6191, doi. 10.1007/s00432-023-04579-4
    By:
    • Wanka, Giulia;
    • Jueckstock, Julia;
    • Wild, Carl Mathis;
    • Vattai, Aurelia;
    • Fürst, Sophie;
    • Heidegger, Helene H.;
    • Kuhn, Christina;
    • Schmoeckel, Elisa;
    • Jeschke, Udo;
    • Dannecker, Christian
    Publication type:
    Article
    19

    Prostaglandin E2 receptor EP1 expression in vulvar cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5369, doi. 10.1007/s00432-022-04487-z
    By:
    • Buchholz, Anna;
    • Vattai, Aurelia;
    • Fürst, Sophie;
    • Vilsmaier, Theresa;
    • Zati Zehni, Alaleh;
    • Steger, Alexander;
    • Kuhn, Christina;
    • Schmoeckel, Elisa;
    • Dannecker, Christian;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Heidegger, Helene H.
    Publication type:
    Article
    20

    High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4293, doi. 10.1007/s00432-022-04271-z
    By:
    • Beyer, Susanne;
    • Müller, Lena;
    • Mitter, Sophie;
    • Keilmann, Lucia;
    • Meister, Sarah;
    • Buschmann, Christina;
    • Kraus, Fabian;
    • Topalov, Nicole E.;
    • Czogalla, Bastian;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Mahner, Sven;
    • Schmoeckel, Elisa;
    • Löb, Sanja;
    • Corradini, Stefanie;
    • Kessler, Mirjana;
    • Jeschke, Udo;
    • Kolben, Thomas
    Publication type:
    Article
    21

    Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3323, doi. 10.1007/s00432-022-04098-8
    By:
    • Kolben, Thomas;
    • Müller, Lena;
    • Meister, Sarah;
    • Keilmann, Lucia;
    • Buschmann, Christina;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Czogalla, Bastian;
    • Mitter, Sophie;
    • Schmoeckel, Elisa;
    • Corradini, Stefanie;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Kessler, Mirjana;
    • Beyer, Susanne
    Publication type:
    Article
    22
    23
    24
    25

    Lysine-specific histone demethylase 1A (LSD1) in cervical cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 11, p. 2843, doi. 10.1007/s00432-020-03338-z
    By:
    • Beilner, Daniel;
    • Kuhn, Christina;
    • Kost, Bernd P.;
    • Jückstock, Julia;
    • Mayr, Doris;
    • Schmoeckel, Elisa;
    • Dannecker, Christian;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Heidegger, Helene Hildegard
    Publication type:
    Article
    26
    27
    28

    Expression of H3K4me3 and H3K9ac in breast cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 8, p. 2017, doi. 10.1007/s00432-020-03265-z
    By:
    • Berger, Luisa;
    • Kolben, Thomas;
    • Meister, Sarah;
    • Kolben, Theresa M.;
    • Schmoeckel, Elisa;
    • Mayr, Doris;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Ditsch, Nina;
    • Beyer, Susanne
    Publication type:
    Article
    29
    30
    31
    32

    EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 10, p. 2519, doi. 10.1007/s00432-019-03017-8
    By:
    • Czogalla, Bastian;
    • Kuhn, Christina;
    • Heublein, Sabine;
    • Schmöckel, Elisa;
    • Mayr, Doris;
    • Kolben, Thomas;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Hester, Anna
    Publication type:
    Article
    33

    The role of EP3-receptor expression in cervical dysplasia.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 2, p. 313, doi. 10.1007/s00432-018-2785-3
    By:
    • Hester, Anna;
    • Ritzer, Manuel;
    • Kuhn, Christina;
    • Schmoeckel, Elisa;
    • Mayr, Doris;
    • Kolben, Thomas;
    • Dannecker, Christian;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Kolben, Theresa Maria
    Publication type:
    Article
    34
    35
    36
    37

    Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 9, p. 1637, doi. 10.1007/s00432-017-2420-8
    By:
    • Vattai, Aurelia;
    • Akyol, Elif;
    • Kuhn, Christina;
    • Hofmann, Simone;
    • Heidegger, Helene;
    • Koch, Franz;
    • Hermelink, Kerstin;
    • Wuerstlein, Rachel;
    • Harbeck, Nadia;
    • Mayr, Doris;
    • Spitzweg, Christine;
    • Toth, Bettina;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Ditsch, Nina
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50